Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -18.70% |
| Q3 2025 | 0.22% |
| Q2 2025 | -0.97% |
| Q1 2025 | -5.73% |
| Q4 2024 | 6.66% |
| Q3 2024 | -2.09% |
| Q2 2024 | 19.83% |
| Q1 2024 | -13.37% |
| Q4 2023 | 9726.18% |
| Q3 2023 | -99.00% |
| Q2 2023 | 11376.45% |
| Q1 2023 | -99.06% |
| Q4 2022 | 8187.07% |
| Q3 2022 | -98.38% |
| Q2 2022 | 10409.45% |
| Q1 2022 | -98.74% |
| Q4 2021 | 6496.88% |
| Q3 2021 | -97.88% |
| Q2 2021 | 6868.69% |
| Q1 2021 | -95.69% |
| Q4 2020 | 1721.87% |
| Q3 2020 | -98.51% |
| Q2 2020 | 22.80% |
| Q1 2020 | 6487.27% |
| Q4 2019 | -98.63% |
| Q3 2019 | -7.91% |
| Q2 2019 | 48.62% |
| Q1 2019 | -6.70% |
| Q4 2018 | 13.54% |
| Q3 2018 | 5.83% |
| Q2 2018 | 80.13% |
| Q1 2018 | -47.16% |
| Q4 2017 | 31.54% |
| Q3 2017 | 740.62% |
| Q2 2017 | -85.55% |
| Q1 2017 | -45.85% |
| Q4 2016 | 70.97% |
| Q3 2016 | 185.02% |
| Q2 2016 | -76.58% |
| Q1 2016 | -33.07% |